Confirmatory Trials: US FDA Toughens Stance On Need For Advance Planning, Due Diligence

Strategies championed by the Oncology Center of Excellence, including early planning and use of a single randomized study to support accelerated approval and later verify clinical benefit, are reflected in a new draft guidance broadly applicable to drugs and biologics.